Simultaneous regression of non-small cell lung cancer and orbital extranodal marginal zone lymphoma with chemoradiotherapy for lung cancer

This report describes the case of a 79-year-old Japanese man diagnosed with orbital extranodal marginal zone lymphoma (EMZL) and stage IIIA lung cancer. The patient received concurrent chemoradiation for lung cancer with carboplatin/paclitaxel treatment, resulting in regression of both the lymphoma and lung cancer. To our knowledge, this is the first reported case of concurrent orbital EMZL and lung cancer. In this case, a treatment strategy that prioritized lung cancer treatment was deemed appropriate. This case suggests that chemotherapy with carboplatin and paclitaxel may serve as an effective treatment for both lung cancer and lymphoma.

Automated summary

This report presents a case of a 79-year-old Japanese man with orbital extranodal marginal zone lymphoma (EMZL) and stage IIIA lung cancer. The patient underwent concurrent chemoradiation for lung cancer using carboplatin/paclitaxel treatment, which led to regression of both the lymphoma and lung cancer. To our knowledge, this is the first reported case of concurrent orbital EMZL and lung cancer. The case suggests that chemotherapy with carboplatin and paclitaxel may be an effective treatment for both lung cancer and lymphoma.